We are live on ! Find out more
FV2GP

Flagship Ventures 2007 General Partner Portfolio holdings

AUM $107M
This Fund
S&P 500
This Quarter Est. Return
+15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow %
112.74%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$95.3M
2
RNAC icon
Cartesian Therapeutics
RNAC
+$23.1M
3
CARM
Carisma Therapeutics
CARM
+$2.41M
4
REGI
Renewable Energy Group, Inc.
REGI
+$310K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.72%
2 Materials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
1
Agios Pharmaceuticals
AGIO
$2.36B
$80.9M 75.24%
+1,930,369
New +$95.3M
RNAC icon
2
Cartesian Therapeutics
RNAC
$243M
$23.1M 21.5%
+55,062
New +$23.1M
CARM
3
DELISTED
Carisma Therapeutics
CARM
$3.2M 2.98%
+95,350
New +$2.41M
REGI
4
DELISTED
Renewable Energy Group, Inc.
REGI
$296K 0.28%
+33,570
New +$310K

Similar funds

EIGI
Elmrox Investment Group IM New York $107M AUM
BPV
Battery Partners VII Boston, Massachusetts $108M AUM 8.59% 1-Year Est. Return
HDE
Hutner Daniel Ellsworth $117M AUM
WCM
Weyland Capital Management Portsmouth, New Hampshire $94M AUM 1.28% 1-Year Est. Return
NCM
Newgate Capital Management Greenwich, Connecticut $121M AUM 3.73% 1-Year Est. Return
WCM
Wesley Capital Management New York $86M AUM 10.39% 1-Year Est. Return
EGA
Emerging Global Advisors New York $140M AUM 5.42% 1-Year Est. Return
TAG
Tactical Allocation Group Birmingham, Michigan $62.6M AUM 2.17% 1-Year Est. Return

Flagship Ventures 2007 General Partner's Q2 2016 Portfolio in Review

Q2 2016 is the first quarter with a 13F filing on record for Flagship Ventures 2007 General Partner, which disclosed 4 positions worth $107M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Agios Pharmaceuticals: 1,930,369 shares worth $80.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Materials.

  • Flagship Ventures 2007 General Partner's largest Q2 2016 buy was Agios Pharmaceuticals: 1,930,369 shares worth $80.9M.
  • Flagship Ventures 2007 General Partner's ten largest holdings make up 100% of its $107M portfolio in Q2 2016.
  • Flagship Ventures 2007 General Partner disclosed 4 positions in Q2 2016, its first 13F filing on record.

Based on Flagship Ventures 2007 General Partner's 13F filing for Q2 2016, filed 15 Aug 2016.